Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan-Inge Henter

Showing results (81-90 of 167) with videos related to

Pageof 17
Sort By:
Stem Cells and Development|June 29, 2012
Treatment of familial hemophagocytic lymphohistiocytosis with third-party mesenchymal stromal cellsDimitrios Mougiakakos, Maciej Machaczka, Regina Jitschin, et al.
Clinical Immunology (Orlando, Fla.)|April 14, 2020
Foxp3<sup>+</sup> Tregs from Langerhans cell histiocytosis lesions co-express CD56 and have a definitively regulatory capacityJenée Mitchell, Jason Kelly, Egle Kvedaraite, et al.
British Journal of Haematology|March 30, 2007
Low plasma levels of the protein pro-LL-37 as an early indication of severe disease in patients with chronic neutropeniaJenny Karlsson, Göran Carlsson, Kim Göransdotter Ramme, et al.
Frontiers in Immunology|March 17, 2022
Simple Evaluation of Clinical Situation and Subtypes of Pediatric Hemophagocytic Lymphohistiocytosis by Cytokine PatternsXiao-Jun Xu, Ze-Bin Luo, Hua Song, et al.
British Journal of Haematology|November 18, 2020
Severe congenital neutropenia-associated JAGN1 mutations unleash a calpain-dependent cell death programme in myeloid cellsAvinash Khandagale, Teresa Holmlund, Miriam Entesarian, et al.
Cell Cycle (Georgetown, Tex.)|April 25, 2017
SAMHD1 protects cancer cells from various nucleoside-based antimetabolitesNikolas Herold, Sean G Rudd, Kumar Sanjiv, et al.
British Journal of Haematology|August 20, 2008
Characterization of PRF1, STX11 and UNC13D genotype-phenotype correlations in familial hemophagocytic lymphohistiocytosisAnnaCarin Horne, Kim Göransdotter Ramme, Eva Rudd, et al.
Frontiers in Oncology|February 7, 2022
Neutralizing Anti-IL-17A Antibody Demonstrates Preclinical Activity Enhanced by Vinblastine in Langerhans Cell HistiocytosisSelma Olsson Åkefeldt, Mohamad Bachar Ismail, Alexandre Belot, et al.
Acta Paediatrica (Oslo, Norway : 1992)|October 25, 2011
Risk factors for early death in children with haemophagocytic lymphohistiocytosisHelena Trottestam, Elisabet Berglöf, AnnaCarin Horne, et al.
Blood|December 20, 2007
Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensificationHelmut Gadner, Nicole Grois, Ulrike Pötschger, et al.
Pageof 17

Showing results (81-90 of 167) with videos related to

Sort By:
Pageof 17
Stem Cells and Development|June 29, 2012
Treatment of familial hemophagocytic lymphohistiocytosis with third-party mesenchymal stromal cellsDimitrios Mougiakakos, Maciej Machaczka, Regina Jitschin, et al.
Clinical Immunology (Orlando, Fla.)|April 14, 2020
Foxp3<sup>+</sup> Tregs from Langerhans cell histiocytosis lesions co-express CD56 and have a definitively regulatory capacityJenée Mitchell, Jason Kelly, Egle Kvedaraite, et al.
British Journal of Haematology|March 30, 2007
Low plasma levels of the protein pro-LL-37 as an early indication of severe disease in patients with chronic neutropeniaJenny Karlsson, Göran Carlsson, Kim Göransdotter Ramme, et al.
Frontiers in Immunology|March 17, 2022
Simple Evaluation of Clinical Situation and Subtypes of Pediatric Hemophagocytic Lymphohistiocytosis by Cytokine PatternsXiao-Jun Xu, Ze-Bin Luo, Hua Song, et al.
British Journal of Haematology|November 18, 2020
Severe congenital neutropenia-associated JAGN1 mutations unleash a calpain-dependent cell death programme in myeloid cellsAvinash Khandagale, Teresa Holmlund, Miriam Entesarian, et al.
Cell Cycle (Georgetown, Tex.)|April 25, 2017
SAMHD1 protects cancer cells from various nucleoside-based antimetabolitesNikolas Herold, Sean G Rudd, Kumar Sanjiv, et al.
British Journal of Haematology|August 20, 2008
Characterization of PRF1, STX11 and UNC13D genotype-phenotype correlations in familial hemophagocytic lymphohistiocytosisAnnaCarin Horne, Kim Göransdotter Ramme, Eva Rudd, et al.
Frontiers in Oncology|February 7, 2022
Neutralizing Anti-IL-17A Antibody Demonstrates Preclinical Activity Enhanced by Vinblastine in Langerhans Cell HistiocytosisSelma Olsson Åkefeldt, Mohamad Bachar Ismail, Alexandre Belot, et al.
Acta Paediatrica (Oslo, Norway : 1992)|October 25, 2011
Risk factors for early death in children with haemophagocytic lymphohistiocytosisHelena Trottestam, Elisabet Berglöf, AnnaCarin Horne, et al.
Blood|December 20, 2007
Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensificationHelmut Gadner, Nicole Grois, Ulrike Pötschger, et al.
Pageof 17